Medium-Dose Riboflavin as a Prophylactic Agent in Children With Migraine: A Preliminary Placebo-Controlled, Randomised, Double-Blind, Cross-Over Trial

Cephalalgia- United States

doi 10.1177/0333102410365106

Full Text

Abstract

Available in

Date

Authors

Publisher

SAGE Publications


Related search